Search clinical trials for: SMS995

Total 6 results

Novartis

Completed

Feasibility and Reproducibility of Barostat Assessments of Colorectal Sensation During Colorectal Distention and Its Pharmacological Modulation Using Octreotide

Irritable Bowel Syndrome (IBS)

United Kingdom, United States, Canada, Sweden
Novartis Pharmaceuticals

Completed

Octreotide Efficacy and Safety in First-line Acromegalic Patients

Acromegaly

Spain
Novartis Pharmaceuticals

Terminated

Study Assessing the Efficacy and Safety of Octreotide Acetate in Patients With Acromegaly, With Micro or Macroadenomas

Acromegaly

Mexico
Novartis Pharmaceuticals

Completed

Safety and Efficacy of Long-acting Repeatable Octreotide Acetate for Injectable Suspension vs. Surgery in Treatment-naïve Patients With Acromegaly

Acromegaly
Novartis Pharmaceuticals

Withdrawn

CD19- and CD22-directed CAR-T Cell Therapy in Patients With Acute Lymphoblastic Leukemia

Acute Lymphoblastic Leukemia
Carmen Schade-Brittinger

Completed

Antiproliferative Effect of Octreotide in Patients With Metastasized Neuroendocrine Tumors of the Midgut

Neuroendocrine Tumors

Germany

3

Subscribe